Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT04931823
Phase: Phase 1
Trial Summary: This is a Phase 1, multicenter, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary evidence of antitumor a – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Conjupro Biotherapeutics, Inc.
Acronym:

Pin It on Pinterest